These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 16624609)
1. Renal osteodystrophy in children: a systemic disease associated with cardiovascular manifestations. Langman CB; Brooks ER Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S79-83. PubMed ID: 16624609 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? Levin A; Li YC Kidney Int; 2005 Nov; 68(5):1973-81. PubMed ID: 16221197 [TBL] [Abstract][Full Text] [Related]
3. Mineral bone disorders in chronic kidney disease. Hou YC; Lu CL; Lu KC Nephrology (Carlton); 2018 Oct; 23 Suppl 4():88-94. PubMed ID: 30298663 [TBL] [Abstract][Full Text] [Related]
4. Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure. Cozzolino M; Gallieni M; Brancaccio D; Arcidiacono T; Bianchi G; Vezzoli G J Nephrol; 2006; 19(5):566-77. PubMed ID: 17136683 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D supplementation in CKD. Martin KJ; González EA Clin Nephrol; 2011 Apr; 75(4):286-93. PubMed ID: 21426882 [TBL] [Abstract][Full Text] [Related]
6. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Souqiyyeh MZ; Shaheen FA Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700 [TBL] [Abstract][Full Text] [Related]
7. Vascular calcification and renal osteodystrophy relationship in chronic kidney disease. Moe SM Eur J Clin Invest; 2006 Aug; 36 Suppl 2():51-62. PubMed ID: 16884398 [TBL] [Abstract][Full Text] [Related]
8. Nutritional vitamin D in CKD: Should we measure? Should we treat? Capelli I; Cianciolo G; Gasperoni L; Galassi A; Ciceri P; Cozzolino M Clin Chim Acta; 2020 Feb; 501():186-197. PubMed ID: 31770508 [TBL] [Abstract][Full Text] [Related]
9. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney disease. Khouzam N; Wesseling-Perry K Pediatr Nephrol; 2019 Jan; 34(1):1-10. PubMed ID: 28939921 [TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295 [TBL] [Abstract][Full Text] [Related]
12. Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy. Hernandez JD; Wesseling K; Salusky IB Semin Dial; 2005; 18(4):290-5. PubMed ID: 16076350 [TBL] [Abstract][Full Text] [Related]
13. [Vitamin D metabolism and chronic kidney disease]. Honda H; Sanada D; Akizawa T Clin Calcium; 2006 Jul; 16(7):1143-46. PubMed ID: 16816474 [TBL] [Abstract][Full Text] [Related]
14. [Role of paracalcitol in the management of non-dialysis CKD: state of art and... Unmet needs]. Mascia S; Garofalo C; Donnarumma G; Di Pietro R; Liberti ME; Pacilio M; Sagliocca A; Zamboli P; Minutolo R; Conte G; De Nicola L G Ital Nefrol; 2010; 27(6):616-28. PubMed ID: 21132644 [TBL] [Abstract][Full Text] [Related]
15. Old and New Drugs for the Management of Bone Disorders in CKD. Komaba H; Ketteler M; Cunningham J; Fukagawa M Calcif Tissue Int; 2021 Apr; 108(4):486-495. PubMed ID: 33386480 [TBL] [Abstract][Full Text] [Related]